Detalhe da pesquisa
1.
PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma.
Int J Cancer
; 155(2): 203-210, 2024 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619111
2.
Casein kinase 1α has a non-redundant and dominant role within the CK1 family in melanoma progression.
BMC Cancer
; 16: 594, 2016 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27488834
3.
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis.
Dis Model Mech
; 17(1)2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251799
4.
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo.
Cancer Res Commun
; 3(9): 1743-1755, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674529
5.
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.
J Exp Clin Cancer Res
; 42(1): 175, 2023 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37464364
6.
MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop.
Exp Dermatol
; 21(4): 265-70, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22417301
7.
Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition.
Cell Death Dis
; 11(7): 581, 2020 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32719412
8.
Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion.
Cancers (Basel)
; 12(8)2020 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32824741
9.
Staphylococcus aureus Skin Colonization Is Enhanced by the Interaction of Neutrophil Extracellular Traps with Keratinocytes.
J Invest Dermatol
; 140(5): 1054-1065.e4, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857094
10.
Lugdunin amplifies innate immune responses in the skin in synergy with host- and microbiota-derived factors.
Nat Commun
; 10(1): 2730, 2019 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227691
11.
YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT.
Mol Cancer Res
; 16(7): 1149-1160, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743296
12.
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase.
Oncotarget
; 8(22): 35761-35775, 2017 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28415756
13.
PTEN regulates IGF-1R-mediated therapy resistance in melanoma.
Pigment Cell Melanoma Res
; 28(5): 572-89, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26112748
14.
ß-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance.
PLoS One
; 6(8): e23429, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21858114
15.
Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis.
Cancer Res
; 70(17): 6999-7009, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20699366
16.
The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
Int J Cancer
; 120(10): 2110-8, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17266041